By Soyoung Kim and Greg Roumeliotis
NEW YORK (Reuters) - U.S. drugstore chain operator WALGREEN (WAG.NY)Co
The Deerfield, Illinois-based company has hired Bank of America Corp
On offer is a controlling stake of just over 50 percent in Walgreens Infusion Services, which has annual earnings before interest, tax, depreciation and amortization of around $105 million, one of the people added.
The sources asked not to be identified because the talks are confidential. Walgreen declined to comment while a Bank of America spokesman did not respond to a request for comment.
With a staff of more than 1,600 clinicians, the unit for sale offers infusion services at home and at care centers across the United States. Its infusion therapies are used for medical conditions such as bleeding disorders and serious infections.
Walgreen is currently the largest U.S. provider of home-infusion services. The company solidified that position in 2010 when it swapped its long-term care pharmacy business for the home infusion business of Omnicare Inc
A deal for Walgreens Infusion Services would come after rival CVS Health Corp
Walgreen has a history of working with private equity. In 2012, Walgreens acquired a 45 percent stake in European health and beauty group Alliance Boots for $6.7 billion, partnering with buyout firm KKR & Co LP
Last month, Walgreen said it would buy the remaining 55 percent it does not already own of Alliance Boots for $5.3 billion in cash and 144.3 million shares for a total deal of about $15 billion.
(Reporting by Soyoung Kim and Greg Roumeliotis in New York; Editing by Lisa Shumaker)
Relacionados
- FACUA exige a las CCAA transparencia en sus protocolos de protección de datos de pacientes del SNS
- El 77% de las recetas del SNS se dispensa de forma electrónica y 12 CCAA comparten ya historias clínicas digitales
- Cristina Ibarrola, nueva directora gerente del SNS, e Isabel Ansa, directora general de Salud
- La consejera de Salud cesa a Juan José Rubio como director gerente del SNS